 |
 |
 |
 |
 |
 |
ABEC designs and ship the world's largest bioreactors: Multiple 20,000L bioreactors that validate within six months.
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
ABEC ships 21 CFR Part 11 compliant systems (confirmed by third party evaluation). | |||||||||||||||||||
|
||||||||||||||||||||
ABEC designs and ship the world's largest bioreactors: Multiple 20,000L bioreactors that validate within six months. |
||||||||||||||||||||
| ABEC begins shipping PLC-based control systems and Supervisory Control and Data Acquisition (SCADA) packages. | ||||||||||||||||||||
| click here to meet our management team | ||||||||||||||||||||
| ABEC advances stirred tank cell culture mixing with the low shear “Elephant Ear” impellor and 15° offset agitation. | ||||||||||||||||||||
| ABEC builds a pilot mammalian cell production facility to produce TPA, one of the first commercially successful mammalian cell products. Almost two thirds of subsequent bioprocess systems designed and built by ABEC are either mammalian cell or dual purpose reactors. | ||||||||||||||||||||
| ABEC founded to design and manufacture aseptic pilot and production scale bioprocess equipment. Early innovations include electropolished vessel surfaces to improve cleanability and a non-pressurized agitator seal housing to eliminate the possibility of contamination from the outside environment. | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|